Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I

A Palmieri1, R Manara, L Bello

  • 1Department of Neurosciences, University of Padua, Via Giustiniani 5, 35121 Padua, Italy. arianna.palmieri@unipd.it

Journal of Neurology
|February 5, 2011
PubMed

Insights

Limb-girdle muscular dystrophy 2I (LGMD2I) patients exhibit mild cognitive deficits, particularly in executive functions. Brain MRI scans in LGMD2I patients revealed heterogeneous findings without a specific pattern.

Area of Science:

  • Neurology
  • Neuroscience
  • Genetics

Background:

  • Limb-girdle muscular dystrophy 2I (LGMD2I) is a neuromuscular disorder caused by mutations in the FKRP gene.
  • The function of the Fukutin Related Protein (FKRP) in the central nervous system (CNS) is not well understood.
  • LGMD2I presents with a heterogeneous clinical phenotype.

Purpose of the Study:

  • To investigate potential cognitive impairments in LGMD2I patients.
  • To describe the brain Magnetic Resonance Imaging (MRI) features in individuals with LGMD2I.

Main Methods:

  • Ten LGMD2I patients and ten matched healthy controls underwent comprehensive neuropsychological testing and psychopathological assessments.
  • Neuromuscular-specific quality-of-life questionnaires were administered.
  • Nine LGMD2I patients had brain MRI scans.

Main Results:

  • LGMD2I patients demonstrated a distinct cognitive profile characterized by mild impairments in executive functions and visuo-spatial planning.
  • Global and logical intelligence quotients (IQ) were not substantially affected.
  • Brain MRI findings were diverse, including non-specific white matter abnormalities, ventriculomegaly, and enlarged subarachnoid spaces, with no specific pattern observed.

Conclusions:

  • Abnormal glycosylation of alpha-dystroglycan in LGMD2I may impact brain development and cognitive functions related to frontal and posterior parietal regions.
  • Despite potential cognitive effects, LGMD2I does not appear to cause specific, identifiable abnormalities on brain MRI scans.